---
title: "禮來公司等申請者在最高法院拒絕多項上訴時被拒絕受理申請"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/286789989.md"
description: "禮來在被最高法院拒絕的製藥公司中，該法院駁回了與醫療保健和商業案件相關的多項上訴。此決定降低了最高法院在這些問題上立即介入的可能性。消息公佈後，禮來的股價下跌了 2.2%，至 985.25 美元"
datetime: "2026-05-18T14:29:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286789989.md)
  - [en](https://longbridge.com/en/news/286789989.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286789989.md)
---

# 禮來公司等申請者在最高法院拒絕多項上訴時被拒絕受理申請

10:29 AM EDT, 05/18/2026 (MT Newswires) -- Eli Lilly ( LLY ) was among the pharmaceutical firms highlighted in Monday's Supreme Court order list, which included widespread denials of certiorari in drugmaker-related and other commercial cases, according to the Court's May 18 orders.

The Court vacated and remanded several cases, including voting rights disputes, while rejecting review in multiple pharmaceutical and healthcare-related petitions, reducing the likelihood of near-term Supreme Court intervention in those matters.

The Court granted review in one education case while denying dozens of appeals across civil, criminal, regulatory, and healthcare matters, with Justice Sotomayor separately concurring in the denial of certiorari in a sentencing case in which relief had already been granted.

Shares of Eli Lilly ( LLY ) were down 2.2% in Monday trading.

Price: 985.25, Change: -19.68, Percent Change: -1.96

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### 相關股票

- [LLY.US](https://longbridge.com/zh-HK/quote/LLY.US.md)
- [LLYX.US](https://longbridge.com/zh-HK/quote/LLYX.US.md)
- [IBB.US](https://longbridge.com/zh-HK/quote/IBB.US.md)
- [IBBQ.US](https://longbridge.com/zh-HK/quote/IBBQ.US.md)
- [XLV.US](https://longbridge.com/zh-HK/quote/XLV.US.md)
- [VHT.US](https://longbridge.com/zh-HK/quote/VHT.US.md)
- [SBIO.US](https://longbridge.com/zh-HK/quote/SBIO.US.md)
- [ELIS.US](https://longbridge.com/zh-HK/quote/ELIS.US.md)
- [LLYZ.US](https://longbridge.com/zh-HK/quote/LLYZ.US.md)
- [PBE.US](https://longbridge.com/zh-HK/quote/PBE.US.md)
- [ARKG.US](https://longbridge.com/zh-HK/quote/ARKG.US.md)
- [XBI.US](https://longbridge.com/zh-HK/quote/XBI.US.md)
- [IHE.US](https://longbridge.com/zh-HK/quote/IHE.US.md)
- [ELIL.US](https://longbridge.com/zh-HK/quote/ELIL.US.md)
- [LABU.US](https://longbridge.com/zh-HK/quote/LABU.US.md)
- [LABD.US](https://longbridge.com/zh-HK/quote/LABD.US.md)
- [IXJ.US](https://longbridge.com/zh-HK/quote/IXJ.US.md)
- [BIB.US](https://longbridge.com/zh-HK/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/zh-HK/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/zh-HK/quote/FBT.US.md)

## 相關資訊與研究

- [巨生醫獲 SelectUSA 醫療科技組金牌 啟動美國 A 輪募資目標 1000 萬美元](https://longbridge.com/zh-HK/news/286905054.md)
- [鉅亨速報 - Factset 最新調查：碩騰 ZTS-US 的目標價調降至 117 元，幅度約 10%](https://longbridge.com/zh-HK/news/286769910.md)
- [禮來公司（LLY）代表了肥胖潮流。市場是否已經將這一因素計入價格中？](https://longbridge.com/zh-HK/news/286727957.md)
- [ADHD 用藥「利他能」缺貨...網友疑考季因素 食藥署：藥廠早通知控貨中](https://longbridge.com/zh-HK/news/286754700.md)
- [特朗普因政策對禮來的藥物有利而購買了禮來的股票](https://longbridge.com/zh-HK/news/286791021.md)